Researchers from the American Cancer Society report that complementary therapy is common among cancer survivors, but its use is significantly influenced by sex, race, age, education, and cancer type. Medscape Medical News
Drs. Oliver Schein and Lisa Keay explore the issues involved in the recent outbreaks of microbial keratitis related to contact lens use. Medscape Ophthalmology
Moxifloxacin monotherapy was comparable to the actions of combination treatment with ceftriaxone plus levofloxacin treatment. Reuters Health Information
Raltegravir, the first-in-class integrase inhibitor, continues to impress with its safety and efficacy, this time with 48-week data from treatment-naïve patients. Medscape Medical News
A survey shows that discussion of breast reconstruction aids in an informed surgical treatment decision-making process and increases the chances that women will choose mastectomy for breast cancer. Medscape Medical News
